Centre Henri Becquerel   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Rouen France (1967)

Organization Overview

First Clinical Trial
2004
NCT00195871
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Centre Henri Becquerel | Centre Henri Becquerel, 76038 Rouen, France | Centre Henri Becquerel de Rouen | Centre Henri Becquerel, ROUEN | Centre Henri Becquerel, Rouen, France | Centre Henri Becquerel, Rouen, France - LYSA

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bone Marrow Diseases (Phase 3)

Bone Neoplasms (Phase 3)

Head and Neck Neoplasms (Phase 2)

Leukemia (Phase 3)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)

Leukemia, Lymphoid (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Follicular (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Multiple Myeloma (Phase 3)

Myelodysplastic Syndromes (Phase 3)

Neoplasm Metastasis (Phase 3)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Prostatic Neoplasms (Phase 3)

Recurrence (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 33